HK1153409A1 - Crystalline tiotropium iodide, the pharmaceutical formulation containing the same and the use thereof - Google Patents

Crystalline tiotropium iodide, the pharmaceutical formulation containing the same and the use thereof

Info

Publication number
HK1153409A1
HK1153409A1 HK11107748.7A HK11107748A HK1153409A1 HK 1153409 A1 HK1153409 A1 HK 1153409A1 HK 11107748 A HK11107748 A HK 11107748A HK 1153409 A1 HK1153409 A1 HK 1153409A1
Authority
HK
Hong Kong
Prior art keywords
same
pharmaceutical formulation
formulation containing
crystalline tiotropium
tiotropium iodide
Prior art date
Application number
HK11107748.7A
Other languages
English (en)
Inventor
Rolf Banholzer
Waldemar Pfrengle
Peter Sieger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34530660&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1153409(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of HK1153409A1 publication Critical patent/HK1153409A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11107748.7A 2003-11-03 2011-07-26 Crystalline tiotropium iodide, the pharmaceutical formulation containing the same and the use thereof HK1153409A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03025075 2003-11-03

Publications (1)

Publication Number Publication Date
HK1153409A1 true HK1153409A1 (en) 2012-03-30

Family

ID=34530660

Family Applications (3)

Application Number Title Priority Date Filing Date
HK09108607.9A HK1129111A1 (en) 2003-11-03 2007-05-25 Tiotropium salts, pharmaceutical formulations containing the salts and the use thereof
HK07105532.7A HK1099748A1 (en) 2003-11-03 2007-05-25 Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
HK11107748.7A HK1153409A1 (en) 2003-11-03 2011-07-26 Crystalline tiotropium iodide, the pharmaceutical formulation containing the same and the use thereof

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HK09108607.9A HK1129111A1 (en) 2003-11-03 2007-05-25 Tiotropium salts, pharmaceutical formulations containing the salts and the use thereof
HK07105532.7A HK1099748A1 (en) 2003-11-03 2007-05-25 Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same

Country Status (35)

Country Link
US (1) US8686148B2 (xx)
EP (3) EP1682541B1 (xx)
JP (1) JP5165244B2 (xx)
KR (1) KR20060117334A (xx)
CN (3) CN101407514B (xx)
AR (1) AR046317A1 (xx)
AT (1) ATE460414T1 (xx)
AU (1) AU2004285683C1 (xx)
BR (1) BRPI0416136A (xx)
CA (1) CA2544348A1 (xx)
CO (1) CO5690553A2 (xx)
CY (2) CY1110048T1 (xx)
DE (1) DE502004010885D1 (xx)
DK (2) DK2067779T3 (xx)
EA (1) EA012326B1 (xx)
ES (2) ES2342468T3 (xx)
HK (3) HK1129111A1 (xx)
HR (1) HRP20100149T1 (xx)
IL (1) IL175023A (xx)
ME (1) ME00361B (xx)
MX (1) MXPA06004697A (xx)
MY (1) MY143364A (xx)
NO (1) NO335814B1 (xx)
NZ (1) NZ547276A (xx)
PE (1) PE20050446A1 (xx)
PL (2) PL1682541T3 (xx)
PT (2) PT1682541E (xx)
RS (2) RS20060292A (xx)
SG (1) SG137859A1 (xx)
SI (2) SI2067779T1 (xx)
TW (2) TWI435876B (xx)
UA (1) UA82413C2 (xx)
UY (1) UY28590A1 (xx)
WO (1) WO2005042526A1 (xx)
ZA (1) ZA200602342B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG137859A1 (en) 2003-11-03 2007-12-28 Boehringer Ingelheim Int Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
SG149876A1 (en) * 2003-11-03 2009-02-27 Boehringer Ingelheim Int Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
NZ583872A (en) * 2005-06-15 2011-10-28 Boehringer Ingelheim Int Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005035112A1 (de) * 2005-07-27 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
TW200738634A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
ES2396978T5 (es) * 2005-12-19 2015-12-04 Sicor, Inc. Forma cristalina novedosa de bromuro de tiotropio y procedimiento para la preparación de la misma
EA015353B1 (ru) * 2006-01-04 2011-06-30 Бёрингер Ингельхайм Интернациональ Гмбх Применение солей тиотропия для лечения персистирующей астмы средней тяжести
EP1953156A1 (de) * 2007-01-29 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopiniumsalzen
CZ201241A3 (cs) 2012-01-20 2013-07-31 Zentiva, K.S. Nové polymorfní formy tiotropium jodidu a zpusob jejich prípravy
WO2014042605A1 (en) * 2012-09-11 2014-03-20 Mahmut Bilgic New tiotropium bromide crystalline form
JP6042197B2 (ja) * 2012-12-11 2016-12-14 エア・ウォーター株式会社 肺障害治療剤

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2597329A (en) * 1947-08-06 1952-05-20 Merck & Co Inc Process for anion exchange of thiamin salts
US3551492A (en) * 1967-10-31 1970-12-29 Ciba Geigy Corp N,n'-diaminoalkoxy-benzyl-diamino-alkanes and the salts thereof
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
JPS6165885A (ja) * 1984-09-07 1986-04-04 Tanabe Seiyaku Co Ltd 新規合成中間体及びその製法
US4811731A (en) 1985-07-30 1989-03-14 Glaxo Group Limited Devices for administering medicaments to patients
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JP3302647B2 (ja) * 1992-04-24 2002-07-15 小野薬品工業株式会社 フェニルアルカン酸エステルの塩酸塩、およびその製造方法
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
JP4023086B2 (ja) 1999-12-27 2007-12-19 和光純薬工業株式会社 スルホニウム塩化合物
EP1430887A1 (de) 2000-10-12 2004-06-23 Boehringer Ingelheim Pharma GmbH & Co.KG Tiotropium-haltige Inhalationspulver
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
MEP40008A (en) * 2000-10-12 2011-02-10 Boehringer Ingelheim Pharma Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
US20020193393A1 (en) * 2001-03-07 2002-12-19 Michel Pairet Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
CN101292964A (zh) * 2000-10-31 2008-10-29 贝林格尔英格海姆法玛两合公司 包含噻托铵盐溶液的可吸入制剂
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
DE10061877A1 (de) 2000-12-12 2002-06-13 Basf Ag Verfahren zur Herstellung wässriger Copolymerisatdispersionen von Copolymerisaten aus Kohlenmonoxid und wenigstens einer olefinisch ungesättigten Verbindung
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) * 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
US20020193394A1 (en) * 2001-03-13 2002-12-19 Bernd Disse Compounds for treating inflammatory diseases
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
AU2003201745A1 (en) 2002-02-11 2003-09-04 Pfizer Limited Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
GB0203193D0 (en) 2002-02-11 2002-03-27 Pfizer Ltd Nicotinamide derivatives useful as pde4 inhibitors
US20030229227A1 (en) * 2002-03-16 2003-12-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg New difurylglycolic acid esters, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
ES2272968T3 (es) 2002-04-04 2007-05-01 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO.KG Formulaciones en polvo, adecuadas para inhalacion.
UA80123C2 (en) 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
DE10216036A1 (de) 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
US6908055B2 (en) * 2003-02-27 2005-06-21 Tandberg Data Asa System for extracting magnetic recording tape from a tape cartridge for engagement with a take-up reel
US20050030040A1 (en) * 2003-06-27 2005-02-10 Mitch Budniak Electrical testing device having voice annunciator
SG137859A1 (en) 2003-11-03 2007-12-28 Boehringer Ingelheim Int Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
SG149876A1 (en) 2003-11-03 2009-02-27 Boehringer Ingelheim Int Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
DE102004041253A1 (de) * 2004-08-26 2006-03-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen
NZ583872A (en) * 2005-06-15 2011-10-28 Boehringer Ingelheim Int Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
US8686148B2 (en) 2014-04-01
CY1114157T1 (el) 2016-08-31
EP2067779B9 (de) 2013-10-16
ZA200602342B (en) 2007-06-27
CN102070630B (zh) 2013-04-17
UY28590A1 (es) 2005-06-30
JP2007509893A (ja) 2007-04-19
ME00361B (me) 2011-10-10
CA2544348A1 (en) 2005-05-12
JP5165244B2 (ja) 2013-03-21
SI1682541T1 (sl) 2010-06-30
HRP20100149T1 (hr) 2010-04-30
CY1110048T1 (el) 2015-01-14
CN1882582A (zh) 2006-12-20
CN102070630A (zh) 2011-05-25
RS51758B (en) 2011-12-31
TW200526653A (en) 2005-08-16
PL1682541T3 (pl) 2010-08-31
AU2004285683C1 (en) 2011-09-08
AU2004285683A1 (en) 2005-05-12
ES2342468T3 (es) 2010-07-07
AU2004285683B2 (en) 2011-04-21
ATE460414T1 (de) 2010-03-15
WO2005042526A1 (de) 2005-05-12
HK1129111A1 (en) 2009-11-20
DK1682541T3 (da) 2010-06-28
EP1682541B1 (de) 2010-03-10
IL175023A0 (en) 2006-08-20
TWI363758B (en) 2012-05-11
NO20061440L (no) 2006-07-12
NO335814B1 (no) 2015-02-23
EP2067779B1 (de) 2013-04-24
PL2067779T3 (pl) 2013-09-30
HK1099748A1 (en) 2007-08-24
IL175023A (en) 2011-02-28
TW201231465A (en) 2012-08-01
ES2422729T3 (es) 2013-09-13
CN101407514A (zh) 2009-04-15
UA82413C2 (uk) 2008-04-10
EP2336126A1 (de) 2011-06-22
RS20060292A (xx) 2008-08-07
EP1682541A1 (de) 2006-07-26
BRPI0416136A (pt) 2007-01-02
PE20050446A1 (es) 2005-08-02
PT1682541E (pt) 2010-04-14
DK2067779T3 (da) 2013-07-29
US20050131007A1 (en) 2005-06-16
EA012326B1 (ru) 2009-08-28
MEP51308A (en) 2011-05-10
AR046317A1 (es) 2005-11-30
CN101407514B (zh) 2013-05-29
PT2067779E (pt) 2013-07-25
EP2067779A1 (de) 2009-06-10
SG137859A1 (en) 2007-12-28
TWI435876B (zh) 2014-05-01
CO5690553A2 (es) 2006-10-31
CN100549010C (zh) 2009-10-14
NZ547276A (en) 2009-08-28
SI2067779T1 (sl) 2013-08-30
KR20060117334A (ko) 2006-11-16
EA200600886A1 (ru) 2006-10-27
MY143364A (en) 2011-04-29
DE502004010885D1 (de) 2010-04-22
MXPA06004697A (es) 2006-07-05

Similar Documents

Publication Publication Date Title
HK1153409A1 (en) Crystalline tiotropium iodide, the pharmaceutical formulation containing the same and the use thereof
IL173602A0 (en) Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same
IL173627A0 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same
IL173051A0 (en) N-glucoside derivatives and pharmaceutical compositions containing the same
IL171997A0 (en) Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same
IL175214A0 (en) 2-cyanopyrrolidinecarboxamide derivatives and pharmaceutical compositions containing the same
IL172159A0 (en) 2-oxo-pyridine derivatives and pharmaceutical compositions containing the same
IL177513A0 (en) Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
ZA200608028B (en) Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
IL174128A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL216734A0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
IL178414A0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
EP1577317A4 (en) NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES, MEDICINAL COMPOSITIONS COMPRISING SAID DERIVATIVES AND MEDICAL USE OF SAID DERIVATIVES
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
IL166232A0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
IL175252A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
IL175127A0 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
IL174249A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL177073A0 (en) Hydroxy-6-heteroarylphenanthridine derivatives and pharmaceutical compositions containing the same
IL175499A (en) Pneumococcal Niraminadase non-toxic and pharmaceutical preparations containing it
ZA200410211B (en) Quinuclidine derivatives and pharmaceutical compositions containing the same.
EP1609799A4 (en) HETEROARYL-5-THIO-BETA-D-GLUCOPYRANOSIDE DERIVATIVES AND AGENTS AGAINST DIABETES THEREOF
IL154370A0 (en) Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same